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Background: Currently, Sub Saharan Africa is faced with a substantial burden from diabetes mellitus. In most of the
African countries, screening for diabetes related complications and control of blood pressure and glycaemic levels is
often suboptimal.
The study aimed at assessing the extent of optimal glycaemic and blood pressure control and the frequency of
screening for diabetic complications in adult ambulatory Ugandan diabetic patients.
Methods: This was a retrospective study of 250 medical records of adult diabetic patients attending the outpatient
diabetic clinic at St. Raphael of St. Francis hospital Nsambya in Kampala, Uganda.
Results: The mean age of the patients was 51.6 ± 9.2 years with the majority being females (155, 62%). Using
fasting blood glucose levels assessed in all the patients, optimal glycemic control of <7.2 mmol/l was noted in
42.8% of the patients. Glycated haemoglobin was performed at least once in the last year in 24 (9.6%) patients , of
which 5 (20.8%) of these attained optimal control of <7%. Optimal blood pressure (BP) control defined as BP ≤140/
80 mmHg was noted in 56% of the patients. Hypertension and diabetic neuropathy were the most screened for
diabetic complications in 100% and 47.2% of the patients respectively and were also the most prevalent diabetic
complications (76.4% and 31.2% respectively).
Conclusions: This study demonstrates that glycemic and blood pressure control and screening for diabetic
complications among the adult ambulatory diabetic patients in this urban diabetic clinic is suboptimal. This
substantiates development and implementation local guidelines to improve diabetes care.
Keywords: Glycaemic and blood pressure control, Screening, Diabetic complications and UgandaIntroduction
There is an estimated exponential increase in the propor-
tion of people living with diabetes mellitus (DM) in the
next two decades with the greatest disease burden to be
documented in low and middle income countries. Accord-
ing to the International Diabetes Federation (IDF) in 2011,
an estimated 366 million people have DM. This figure is
projected to rise to 552 million by 2030 [1].* Correspondence: kibirigedavis@gmail.com
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unless otherwise stated.People living with DM in Sub Saharan Africa (SSA)
are faced with a disproportionate risk of lethal and dis-
abling diabetic complications such as the diabetic foot,
nephropathy, retinopathy, coronary artery disease and
cerebrovascular disease. These lead to significant mortal-
ity among patients with DM [2] and also have a colossal
strain on the existing meager health resources [3].
There is a great need to improve diabetes care among
patients with DM in SSA in order to minimise the de-
velopment of macro and microvascular diabetic compli-
cations. Studies on the quality of diabetes care from
Africa have documented suboptimal screening for diabeticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pressure levels among diabetic patients [4-8].
In Uganda, a low income developing country, there is
also paucity of published information on the extent of gly-
caemic and blood pressure control, frequency of screening
for diabetes complications and magnitude of diabetic com-
plications despite the documented growing prevalence of
DM in the country.
We therefore performed a retrospective study on 250
selected medical records of adult diabetic patients at St.
Raphael of St. Francis hospital Nsambya in Kampala,
Uganda. Its aim was to assess the extent of optimal
glycaemic and blood pressure control and the frequency
of screening for diabetic complications in reference to the
recently published 2013 American Diabetes Association
(ADA) guidelines of standard of medical care of DM
(Table 1) [9]. This information will help propose evidence
to help in the formulation of institutional guidelines of
diabetes care and to institute standard practices of DM
management. This will also directly reduce morbidity and
mortality due to DM complications among our adult
diabetic patients.
Study methods
This study was a descriptive retrospective study of 250
selected medical records of adult diabetic patients who
regularly attended the diabetic clinic within a recent
period of 1 year at St. Raphael of St. Francis hospital
Nsambya in Kampala, Uganda. It was carried out between
June and July 2013. The hospital is a private not-for-profit
hospital located in Kampala, the capital city of Uganda
and serves a predominantly middle and high income
urban population of about 1 million people.
The diabetes clinic operates once a week and is man-
aged by 2 diabetic nurses, intern doctors, internal medi-
cine residents and internists. An average of 60 patients
is seen on each clinic day. Prior to being reviewed by the
doctors, all patients receive diabetic health education of-
fered by the trained diabetic nurses.
The charts of regularly attending patients were reviewed
for a recent documentation of the parameters to assess the
extent of glycemic and blood pressure control. Fasting
blood sugar and glycated haemoglobin (HbA1c) levels asTable 1 2013 American Diabetes Association guidelines of sta
A. Glycemic goals B. Blood pressure
goals
C. Lipid profile go
1. HbA1c ≤ 7% or a
pre-prandial capillary plasma
glucose level of 3.9-7.2 mmol/l
1. Blood pressure of
systolic ≤140 and
diastolic ≤ 80 mmHg
1. LDLC levels of <
in absence of cardio
or < 70 mg/dl or 1.
with overt CVDmeasures of glycaemic control were assessed using a point
of care Accu-Check Active glucometer by Roche diag-
nostics and Roche immunoassay at the hospital’s central
laboratory respectively. Blood pressure measurement of
the patients was performed using a mercury sphygmo-
manometer after a 15 min rest.
The frequency of screening for diabetic complications
within a period of 1 year was also recorded. The complica-
tions included hypertension, diabetic retinopathy, diabetic
neuropathy, diabetic nephropathy, diabetic foot complica-
tions; cardiac complications-ischemic heart disease, dys-
lipidemia, peripheral vascular disease and stroke. Newly
diagnosed and pre-existing diabetes related complications
on screening were also documented. A comprehensive
drug review was also performed.
A diagnosis of diabetic neuropathy was made using mono
filament testing or by assessing for the presence of neuro-
pathic symptoms like burning, pricking sensation or numb-
ness in history. Diabetic retinopathy and nephropathy
among the patients were screened using dilated eye exam-
ination using fundoscopy and measurement of serum cre-
atinine and macroalbuminuria respectively. Diabetic foot
complications and peripheral arterial disease were assessed
using clinical inspection for wounds, ulcers, changes in
skin colour and temperature, loss of toe hair and direct
palpation of feet pulses. Ischemic heart disease and stroke
was assessed using history of suggestive symptoms, med-
ical records and electrocardiography if available.
The criteria used to diagnose diabetes in all these
patients prior to enrolment into the diabetic clinic was
either a fasting random blood sugar ≥ 126 mg/dl, a ran-
dom blood sugar level ≥ 200 mg/dl or HbA1c ≥ 6.5% in
the presence of symptoms of diabetes like polyuria and
polydipsia. Regularly attending patients were defined as
those who had a minimum of 6 documented clinical re-
views at the clinic in the period of 1 year. We selected 250
medical charts of patients who fulfilled that study defin-
ition whose information was extracted and analysed.
Study statistics
Data was entered into an access data base, FoxPro for
windows (Version 2.6; Microsoft) and Stata software,
version 12.1 was used for all statistical analysis. Patientndards of medical care of diabetes mellitus
als D. Laboratory evaluation
100 mg/dl or 2.6 mmol/l
vascular diseases (CVD)
8 mmol/l in individuals
1. Measurement of the glycated haemoglobin
(HbA1c) levels at least once annually.2. Annual
assessment of fasting lipid profile (triglyceride,
total cholesterol and high density lipoprotein
cholesterol (HDLC) and low density lipoprotein
cholesterol (LDLC) levels).3. Annual assessment
of renal function status by measurement of
serum creatinine and calculate an estimated
glomerular filtration rate.
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centage for most variables.Ethical considerations
Approval to carry out this study was sought and obtained
from the Research and Ethics Committee of St. Raphael of
St. Francis hospital Nsambya, Uganda.Results
Baseline and clinical characteristics of the patients
Majority of the patients were females (155[62%]). The
mean age was 51.6 ± 9.2 years with the youngest being
21 years and the oldest 89 years. One hundred forty
(56%) and 235 (94%) patients were employed and had
attained some level of formal education respectively.
Only 3 (1.2%) and 22 (8.8%) patients were documented
to be current and former smokers respectively. Family
history of DM was documented in only 93 (37.2%)
patients. Majority of the patients had type 2 DM (243,
97%) and a normal body mass index (BMI)- (130[52%]).
The mean BMI of the patients was 24.5 ± 3.9 kg/m2
(Table 2).Table 2 Baseline and clinical characteristics of the study
participants (n = 250)
Characteristic Frequency Percentage
Age, years










Former smokers 22 8.8
Current smokers 3 1.2
Family history of diabetes
Yes 93 37.5
Body mass index in kg/m2





Type 2 DM 97
*DM-Diabetes Mellitus.Frequency of screening and attainment of the optimal
glycaemic and blood pressure goals
Frequency of screening and adequacy of glycemic control
Fasting blood glucose (FBG) levels were assessed in all the
patients during the most recent clinical review. Optimal
glycemic control as defined by a FBG ≤7.2 mmol/l was
documented in 107 (42.8%) participants. The mean FBG
was 9.9 ± 5.3 mmol/l.
Glycated haemoglobin (HbA1c) as a measure of asses-
sing glycemic control was performed at least once in the
most recent year in 24 (9.6%) patients. Only 5 (20.8%) of
these had optimal glycemic control as defined by HbA1c
of <7%. The mean HbA1c of the patients was 9.9 ± 2.9%.
Apart from 2 (0.8%) patients who were on conservative
management using diet and exercise, the rest received
pharmacological blood lowering treatment. Majority were
receiving oral hypoglycemic drugs (198, 79.6%) with the
combination of metformin and a sulphonylurea being the
most frequently used (141, 71.2%). Metformin monother-
apy was used in 57 (22.8%) patients. A combination of
metformin and pre-mixed insulin (Mixtard®) was used in
42 (16.8%) patients while only 8 (3.2%) were on insulin
(Mixtard®) monotherapy. Long acting basal insulin regi-
mens, incretin based therapies and α glucosidase inhibi-
tors were not used in any patient.
Frequency of screening and adequacy of blood pressure
control
All patients received blood pressure measurements at each
clinical visit. Optimal blood pressure control as defined as
a blood pressure of ≤140/80 was noted in 140 (56%)
patients. Fifty two (20.8%) patients attained both optimal
glycaemic and blood pressure control. The mean systolic
and diastolic blood pressures were 137.1 (SD 22.1) and
80.7 (SD 12.4) respectively.
Majority of the patients (196[78.4%]) were receiving at
least an anti-hypertensive drug. An angiotensin converting
enzyme inhibitor (ACEI) or angiotensin receptor blocker
(ARB) and calcium channel blocker (CCB) combination
and an ACEI or ARB monotherapy were the most fre-
quently used drug regimens in 79 (40.3%) and 48 (24.5%)
respectively. Only 6 (2.4%) patients received an anti hyper-
tensive regimen without an ACEI or ARB (Table 3).
The use of low dose cardiac aspirin for either primary
or secondary prophylaxis against cardiovascular diseases
was documented in 95 (38%) patients. Low dose cardiac
aspirin, a statin and anti hypertensives were simultan-
eously used in only 36 (14.4%) patients.
Frequency of screening for diabetic complications
Hypertension was the most frequently screened for dia-
betes related complication, performed in all the patients.
Diabetic neuropathy was the second most screened com-
plication in 118 (47.2%) patients.
Table 3 Blood glucose and pressure lowering drugs used
by the study participants (n = 250)
Frequency Percentage
Blood glucose lowering drugs
OHAs alone
Yes 198 79.6
Type of OHA used
Metformin and a SU 141 71.2
Metformin only 57 28.8
Insulin monotherapy
Yes 8 3.2
Pre-mixed insulin and metformin
Yes 42 16.8
Blood pressure lowering drugs
On therapy
Yes 196 78.4
Class of anti hypertensive used.
ACEI/ARB monotherapy 48 19.2
ACEI/ARB and CCB 79 31.6
ACEI/ARB and beta blocker 2 0.8
ACEI/ARB and thiazide diuretic 27 10.8
ACEI/ARB, thiazide diuretic and CCB 29 11.6
ACEI/ARB, thiazide diuretic, CCB and beta
blocker
1 0.4
ACEI/ARB, CCB and beta blocker 5 2
Other anti hypertensives without ACEI/ARBS 6 2.4
OHAs- oral hypoglycemic agents SU- sulphonylurea ACEI-angiotensin converting
enzyme inhibitor ARB- angiotensin II receptor blocker CCB-calcium channel
blocker.
Table 4 Newly diagnosed and pre-existing diabetic
complications (n = 250)





















*TIA- transient ischemic attack.
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for dyslipidemia at least once in a period of 1 year. Re-
sults for only 15 (42.9%) of these screened patients were
available in the medical records. Optimal lipid control as
defined as low density lipo-protein cholesterol (LDLC)
concentrations ≤100 mg/dl was noted in only 3 (20%)
patients. Fifty one (20.4%) patients were on statin therapy
as a lipid lowering therapy. No patient was on a fibrate or
a fibrate and statin combination.
Thirty one (12.4%) patients were screened for diabetic
nephropathy at least once in 1 year and measurement of
the serum creatinine levels was the most frequently used
mode of assessment in 80.6% of the patients. No patient
was assessed for diabetic nephropathy using microalbumi-
nuria measurement. Screening for diabetic retinopathy
(using fundoscopic examination), peripheral vascular dis-
ease (basing on clinical examination for skin colour and
hair changes of the feet and character of the feet pulses),
cardiac complications (using medical records, an electro-
cardiography or/and echocardiography) and feet examina-
tions for diabetic foot ulcers were performed at least oncein 1 year in 14%, 18%, 5.6% and 21.2% of the patients
respectively.
Pre-existing and newly diagnosed diabetic complications on
screening among the patients
Hypertension both newly diagnosed and pre-existing
(controlled and uncontrolled) was the most documented
complication in 191 (76.4%) patients. Diabetic neuropathy,
retinopathy and nephropathy were present in 31.2%, 9.6%
and 2% of the patients respectively.
Among those screened for diabetic retinopathy, cata-
racts and non proliferative retinopathy were present in 16
(6.4%) and 14 (5.6%) patients respectively. Only 1 (0.4%)
patient had glaucoma. Diabetic foot complications were
reported in 8 (3.2%) patients with majority of these having
diabetic ulcers-Wagner classification I-III (6, 75%).
Diabetic macrovascular complications were very infre-
quent among the patients. Peripheral vascular disease,
ischemic heart disease and stroke were reported in 2%,
1.2% and 0.4% of the patients. The frequency of all the
complications is illustrated in Table 4.
Discussion
In this descriptive retrospective study, we explored the
extent of optimal glycaemic and blood pressure control
and frequency of screening for diabetic complications in
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outpatient clinic at an urban hospital in Uganda. This
information evidently demonstrates that according to
the 2013 ADA guidelines of diabetes care, glycemic and
blood pressure control and screening for diabetic compli-
cations is suboptimal in this clinical setting. Attainment of
the recommended glycemic and blood pressure targets is
often not easy in most settings even in developed coun-
tries with adequate health care resources [10].Glycaemic control
In our study population, optimal glycemic control using
HbA1c and FBG levels was noted in 20.8% and 42.8% of
the participants respectively. The probable reasons to
explain the poor glycemic control among this study
population are multifactorial. Financial constraints are a
key factor since all the patients have to buy their drugs.
The prices of some of these drugs are prohibitive to
some patients. Poor adherence to therapy could also
explain the poor glycemic control. Poor prescription pat-
terns of health personnel could also be another reason.
Insulin prescription despite poor glycaemic control is
relatively infrequent among adult diabetic patients dem-
onstrating the aspect of “clinical inertia” among majority
of the health personnel. In our study, only 3.2% and
16.8% of the patients received insulin either as mono-
therapy or in combination with metformin respectively.
Suboptimal glycemic control has also been noted in
similar African studies performed in past years. In studies
performed to assess the quality of diabetes care in specia-
lised diabetes centres in Libya [11] and Ethiopia [7], opti-
mal glycemic control as assessed using FBG levels similar
to what was used in all of our study participants was 9.2%
and 26.9% respectively. The extent of optimal glycemic
control in these studies is inferior to what we noted in our
study population. HbA1c testing in this urban hospital is
available though expensive to some of the patients. A low
inclination to performing HbA1c measurement among
the diabetic patients by the health personnel could also
probably explain why few patients had HbA1c measure-
ment as a measure of assessing glycaemic control.
Other similar studies, though cross sectional in nature
reported from South Africa [12] and Nigeria (the Diabcare
Nigeria study) [6] documented optimal glycemic con-
trol (defined as HbA1c <7%) in 30.4% and 32.4% of
their study populations respectively. The largest multi-
centre descriptive cross sectional study of 2,352 type 2
diabetic patients performed in 6 sub Saharan African
countries to date to study the quality of diabetes con-
trol and co-existing diabetes related complications (the
Diabcare Africa study) reported optimal glycemic control
(defined as HbA1c level < 6.5%) in only 29% of the study
participants [5].Optimal blood pressure control
Optimal blood pressure control was noted in 56% of the
patients as per the 2013 ADA guidelines. The proportion
of patients who attained optimal blood pressure control
is higher than what has been reported in most African
studies [5-7]. The probable reason for this variation is
the different study definition of optimal control used. The
previous ADA guidelines recommended a target blood
pressure of ≤130/80 mmHg which was used in all the
quoted African studies.
In agreement with the guidelines regarding prevention
or retarding progression of diabetic nephropathy, a good
proportion of the patients received anti hypertensive
therapy with an ACEI/ARB (76%). Hypertension as a
co-existing complication was highly prevalent in our
study population (76.4%). Majority of the African stud-
ies have documented similar findings of high frequency
of hypertension among adult diabetics ranging from
44.4% to 65% [5-8].
Frequency for screening for and prevalence of diabetic
complications
With the exception of hypertension, the frequency of
screening for diabetic complications in the last 1 year
was incredibly low. Less than 50% of the patients were
screened for diabetic neuropathy despite its being the
second most prevalent diabetic complication in this
study population (31.2%). Diabetic retinopathy and
nephropathy were screened in less than 15% of the
patients.
Only 21.2% of the patients had at least one foot exam-
ination and eight (3.2%) patients were noted to have dia-
betic foot complications with diabetic ulcers being the
commonest (6, 75%). The most probable aetiology of the
diabetic foot complications in this study population was
diabetic neuropathy due to its high prevalence (31.2%).
A small fraction of patients (2%) had features of periph-
eral vascular insufficiency on clinical examination. This
finding of low prevalence of diabetic foot complications
predominantly of neuropathic type has been replicated
in most African studies in adult diabetic populations [5].
Screening for dyslipidemia, a complication that is highly
prevalent in DM patients was performed only 35 (14%)
study participants, with results documented in only 15
participants. Of these 15 participants, only 3 (42.9%) had
optimal LDLC levels of < 100 mg/dl as per the ADA
guidelines. Lipid lowering therapy (a statin) was prescribed
in 20.4% of the 250 study participants.
Most African studies have reported very low rates of
screening for dyslipidemia and use of lipid lowering rates.
In the Diabcare Africa study, 45% of the patients had their
lipid profile assessed at least once in a year with only 13%
on lipid lowering therapy [5]. In the Diabcare Nigeria
study, 48% of the patients were screened for dyslipidemia
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glyceridemia being the most prevalent lipid abnormalities.
Treatment for hyperlipidemia was reported in only 12.6%
of the patients [6].
Similarly, a low frequency of screening for dyslipid-
emia and use of lipid lowering drugs of 4.9% and 2.7%
respectively was reported in one study done in Ethiopia
[7]. However, in another study performed in Northern
Ethiopia, no cases of hyperlipidemia were found among
105 adult diabetic patients [13]. This universally low rate
of screening for hyperlipidemia and prescription of
statins among adult diabetics in Africa calls for a need
of an urgent intervention in diabetes care. The cost of
assessing lipid profile and purchasing statins and the
health personnel’s low inclination to prescribe statins
could explain these findings.
Screening for macro vascular diabetic complications
was also exceedingly low. Peripheral vascular disease
and cardiac diseases were screened in 18% and 5.6% of
the patients. On screening, macrovascular diabetic com-
plications were noted to be very uncommon in this
study population. Peripheral vascular disease, ischemic
heart disease and stroke or transient ischemic attack
was documented in only 2%, 1.2% and 0.4% of the pa-
tients respectively. This remarkably low frequency of
screening for and prevalence of macrovascular diabetic
complications have also been described in most African
studies [5-7,13]. In the Diabcare Africa [5] and Diabcare
Nigeria [6] studies, stroke, myocardial infarction or cor-
onary artery by-pass graft or angiography was reported
in less than 5% of the patients. No evidence of macro-
vascular diabetic complications was found in an adult
diabetic population in one study performed in North
Ethiopia [13].
This low frequency among adult African diabetic pa-
tients and sub Saharan African (SSA) population in gen-
eral could be explained by the genetic influence, low
frequency of smoking, lipid abnormalities and screening
in clinical practice.
Conclusion
In this single centre study, glycemic and blood pressure
control and screening for diabetic complications among
ambulatory adult diabetics was suboptimal. Majority of
the patients were hypertensive and had diabetic neur-
opathy. Macrovascular diabetic complications were very
infrequent.
Local diabetes care policies adapted from the ADA
guidelines of diabetes management should be urgently
developed and implemented. Regular comprehensive dia-
betic education to patients and diabetic health programs
for health care personnel should be encouraged as princi-
pal steps in improving health outcomes and quality of dia-
betes care. Provision of point of care HbA1c and lipidprofile testing in most diabetic clinics in the country
may also improve on patient monitoring and treatment
outcomes.
Study limitations
Due to the study design, our study is absolutely associated
with the similar demerits of retrospective studies. Due to
the small sample size and selection bias, these findings
cannot be extrapolated to general diabetes care in Uganda.
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